NSETrading Window2d ago · 28 Oct 2026, 04:35 pm
Trading Window
Paras Healthcare Limited · PARASHLTH
✦ AI SummaryRegulatory
Paras Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will be closed from October 28, 2026, till forty-eight hours after the declaration of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Paras Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
PARASHEALTH_28102026163517_Trading_Window_closure_October_28_2026.pdf
View document text
Date: October 28, 2026
To, To,
National Stock Exchange of India Limited, BSE Limited,
Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers,
Bandra Kurla Complex, Dalal Street, Mumbai – 400001
Bandra (E), Mumbai – 400051 BSE Scrip Code: 545005
NSE Scrip Symbol: PARASHLTH
Subject: Closure of Trading Window under Securities and Exchange Board of India
(Prohibition of Insider Trading) Regulations, 2015 (“SEBI PIT Regulations”)
Dear Sir/Madam,
This is to inform you that pursuant to the provisions of the SEBI PIT Regulations and the
Company’s Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing
in Company’s securities shall be closed from Wednesday, October 28, 2026, till forty-eight (48)
hours after the declaration of Unaudited Standalone and Consolidated Financial Results
(“Financial Results”) of the Company for the quarter and half year ended September 30, 2026.
Accordingly, all the Designated Persons of the Company and their immediate relatives shall be
strictly prohibited to deal in the securities of the Company during the aforesaid period.
Date of the Meeting of the Board of Directors, proposed to be held, inter-alia, to consider and
approve the aforesaid Financial Results will be intimated in due course.
This disclosure will also be hosted on the Company’s website at
https://www.parashospitals.com/investors.
We request you to kindly take the above information on record.
Thanking you.
For Paras Healthcare Limited
Rahul Kumar
Company Secretary and Compliance Officer
ICSI Membership No.: A20928